feed,title,long_url,short_url
Benzinga,"Apellis Pharma Flunks On Primary, Secondary Endpoints In Amyotrophic Lateral Sclerosis Study",https://benzinga.com/general/biotech/23/05/32577827/apellis-pharma-flunks-on-primary-secondary-endpoints-in-amyotrophic-lateral-sclerosis-study,https://da.gd/QbNI9
Benzinga,The Next Crypto Sensation: Base's Mainnet Launch And What It Means For You,https://benzinga.com/markets/cryptocurrency/23/05/32578002/the-next-crypto-sensation-bases-mainnet-launch-and-what-it-means-for-you,https://da.gd/QiweY
